Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Clinical Decision Making- Summer > HIV-1 schoenwald > Flashcards

HIV-1 schoenwald Flashcards

1
Q

HIV is a disease of cell mediated immunity– ____ cells

A

CD4 cells* (T cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HIV cases are presented with opportunistic infections i.e. ____

A

PCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HIV transmission: list 3 routes and ex’s of each

A
  1. Blood (ie transfusion/injections (drugs)
  2. Sexual intercourse (heterosexual** male to male MC)
  3. Perinatal (ie intrapartum and breast feeding)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

___:___ is the risk from sharing needles in IVD

A

1:150

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

___:___ is the risk to hcw w/ needlestick

A

1:300. (hcw=healthcare worker)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Blood transfusion with infected blood risk?

Perinatal risk w/ antiretriviral?

A
  • 95%

- 13-40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HIV=

A

presence of virus without AIDS defining illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AIDs (list 2 definitions)

A
  • HIV + with AIDS defining illnesses (as listed in Current Medical Diagnosis and Treatment)
  • **HIV + with CD4 count <200
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List Ex’s of AIDS defining illnesses

A

-THRUSH is NOT an AIDs defining illness BUT–> Candidiasis of bronchi, trachea, or lungs or esophageal is
-Kaposi’s sarcoma
-Pneumocystis carinii (jirovicci) PNA
Burkitt’s lymphoma
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIV Sx:

HIV MC presentation?

A
  • can be asymptomatic for years
  • +/- Fever, night sweats, unexpected weight loss, LAD

-MC: asymptomatic and found via screening tests, **commonly presents w/ opportunistic infxn THEN found to have HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recommended to screen anyone with new dx of ______ for HIV

A

Syphilis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

_____ HIV most likely to have sx

A

acute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pneumocystis jiroveci (humans):

  • classified as: ?
  • gold standard dx test?
  • Newer tests ?
A
  • a fungus
  • Gold standard**= silver stain on sputum sample
  • newer= PCR based methodology
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pneumocystis Jiroveci:

-Chest X ray reveals** ______

A

**Bilateral hilar infiltrate

-CT scan shows brown glass opacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pneumocystis pneumonia Sx: (list)

A

Fever
Dry cough
Shortness of breath-desaturation of oxygen
fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pneumocystis tx ?

A

High dose trimethoprim/sulfamethoxazole
15-20 mg/kg IV q day divided into q 6-8 hour dosing

-Prednisone 40 mg PO BID added if paO2<70mm/HG

**PEARL: often present w/ severe hypoxemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PCP prophylaxis at CD4 count of _____

A

<200
first line: Trimethoprim/sulfamethoxazole po

-Dapsone or inhaled pentamidine are alternates if sulfa allergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Kaposi’s Sarcoma= Human herpes virus __

A

8**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Kaposi’s SarcomaSx?

-tx?

A
  • **Purplish, brownish lesions
  • Can be body wide, including inside of mouth

tx: reconstitute the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

HIV:

-can be a retrovirus that depends on ______

A

reverse transcriptase–RNA dependent DNA polymerase to replicate

  • *HIV 1 most prevalent in US
  • HIV 2 is rare in the US, but less virulent– most confined to west africa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

when HIV enters the body, it enters ____ cells via _____ receptors

A

CD4 cells via chemokine receptors(CCR5 and CXCR4)

  • **people w/ CCR5 deletions are less likely to become infected
  • once in cell–> HIV replicates and causes cell fusion/or death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HIV latent state (describe)

-what happens to CD4 count

A

integration of HIV genome into cell genome

**CD4 count falls with increasing length of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HIV: list ex’s of S/Sx

A 
Asymptomatic
Fever, night sweats and weight loss
Presence of opportunistic infection
Kaposi’s sarcoma
Lymphoma
-Oral lesions such as hairy leukoplakia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acute HIV aka _____

-describe sx?

A

Acute Retroviral Syndrome (time frame of first 12 weeks post exposure to HIV infxn)

  • Non specific “flu-like Sx”
  • Fever, fatigue, pharyngitis, LAD, Body wide maculopapular Rash*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Who should be tested for HIV?

A
  • 13 and 64yo
  • Injection drug users and their sex partners
  • Persons who exchange sex for money or drugs
  • Sex partners of HIV infected persons
  • MSM or heterosexual persons who themselves or whose sex partners have had sex with more than one sex partner since their most recent sex partner
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

testing for HIV?

A

-combination aka 4th generation testing (EIA) is reccomended over ELISA for screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Describe mechanism for Combination HIV testing

A
  • Measurses HIV AB and p24 Ag

- Confirmation is HIV RNA by PCR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Other HIV testing methods?

A
  • CD4
  • Ultrasensitive quantitative rna by PCR (viral load)
  • Rapid testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

ELISA (aka the old test of choice for HIV)–> looks for _____

vs

combination or 4th generation–> looks for both ____ and _____

A

antibody only*
-and it takes 4-12 weeks for antibody to develop

-HIV antibody and p 24 antigen
2-6 weeks from exposure to positivity —>Now test of choice for testing, confirm with NAT-(HIV rna by pcr)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

How to measure a Pt’s response to HIV tx?

A
  • CD4 count

- Viral load (VL) –> Drug resistance= VL >1000

31
Q

HIV Pts:

-what other screening tests should be performed?

A
  • Hep A,B, and C
  • TB and Toxoplasmosis
  • STDs (syphilis, chlamydia, gonorrhea, etc)
32
Q

HIV tx:

-list Ex’s

A
  • *HAART= highly active antiretroviral therapy– now referred to as antiretroviral therapy**
  • -> Protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTI), non nucleoside reverse transcriptase inhibitors (NNRTI) and integrase inhibitors standard
33
Q

Goals of HIV therapy (list top 5)

A
  • Suppression of viral load to <50 copies per ml
  • Restoration of immune function (CD4 count)
  • Prevention of HIV transmission
  • Prevention of drug resistance
  • Improvement in quality of life
34
Q

HIV regimen:

-backbone=

A

2 nucleoside reverse transcriptase inhibitors (NRTIs)

35
Q

HIV regimen:

-base=

A

traditionally included either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or Protease Inhibitor (PI), or integrase inhibitor reltegravir

36
Q

Nucleoside Reverse Transcriptase Inhibitors (NRTIs):

Newer choices?

A
  • Emtricitabine (FTC)
  • Tenofovir (TAF)

Less Use 2° ADRs

  • Didanosine (ddI)
  • Stavudine (d4T)
  • Abacavir (ABC)
37
Q

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

-1st line choices?

A

Nevirapine (NVP)
Delavirdine (DLV)
Efavirenz (EFV)

38
Q

HIV meds:

-Tenofovir has 2 formulations–> list? (why is the newer formulation better?)

A

Tenofovir disoproxil(old) higher risk of causing renal failure and osteoporosis

**Tenofovir alafenamide-(new) lessened renal and bone risks

39
Q 
Protease Inhibitors (PIs) (-"navir drugs"**)
-list the ones that are STILL recommended
A
  • Ritonavir (RTV)
  • Lopinavir (LPV)
  • Atazanavir (ATV)
  • Darunavir (DRV) preferred= 1st line (KNOW)
40
Q

Integrase Strand Transfer Inhibitors (INSTIs) (-egravir drugs) list ex’s

A

Use 2 nucleoside inhibitors and add in 1 integrase strand transfer inhibitors like: Raltegravir or Elvitegravir

41
Q

HIV combination meds (once daily dosing) (list Ex’s of common combination pills)

A
  • Atripla: (Tenofovir disoproxil/emtricitabine/efavirenz
  • Stribild: (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil
  • Genvoya: elvitegravir/cobicistat/emtricitabine/ tenofovir alafenamide
  • Complera: emtricitabine/rilpivirine/tenofovir disoproxil fumarate
  • Odefsey: emtricitabine/rilpivirine/tenofovir alafenamide
42
Q

When should treatment be started:
-historically based on ______ count
VS
MOST recent guideline?

A

*CD4 count –>500- monitor
<500 consider initiation of treatment
<350 treatment initiated

  • January 2020: states that all HIV + should be considered for initiation of treatment
  • -Continuation of 1st recommendation in 2016 (ANYTIME someone is dx w/ HIV they should be offered tx)
43
Q

Initial Treatment: Choosing Regimens

-3 main categories?

A

-1 II + 2 NRTIs
-1 PK-boosted PI + 2 NRTIs
-1 NNRTI + 2 NRTIs
–Combination of II, boosted PI, or NNRTI + 2 NRTIs is preferred for most patients
NRTI pair should include 3TC or FTC

44
Q

MC regimen**

A

2 NRTIs (FTC + TAF) + 1 NNRTI (ex.EFV) (historic option)
OR
+ 1 INSTIs (ex. RAL) (preferred)
OR
+ “boosted”PI (DRV)
OR
*boosted with ritonavir or cobicistat

45
Q

Untreated HIV is assoc. w/ development of _____ and ______

A

*AIDS and non-AIDS-defining conditions

46
Q

Earlier Aids related therapy (ART) may prevent:

A

HIV-related end-organ damage; deferred ART may not reliably repair damage acquired earlier
-ALSO: more evidence that HIV in of itself causes enough inflammation to cause end organ damage

47
Q

which NRTIs are MC used?

A

**Emtricitabine (FTC) &
Tenofovir (TAF)

+ ! **INSTI– Raltegravir (RAL)- 1st line (preferred to do INSTI + 2 NRTIs)

OR
+
1 NNRTI (ie Efavirenz (EFV)) (historic choice)

48
Q

Benefits of Early therapy:

Potential decrease in risk of many complications, including–> list Ex’s

A

HIV-associated nephropathy

Liver disease progression from hepatitis B or C

Cardiovascular disease

Malignancies (AIDS defining and non-AIDS defining)

Neurocognitive decline

Blunted immunological response owing to ART initiation at older age

Persistent T-cell activation and inflammation

49
Q

Describe CD4 monitoring with HIV therapy:

A
  • check @ baseline (x2) and every 3-6 months
  • immediately before initiating ART
  • Every 3-6 months during first 2 yrs of ART or if CD4 <300
  • After 2 yrs on ART w/ HIV RNA consistently surpressed:
  • -CD4 300-500: Q 12 months
  • -CD4 >500: optional
  • -more frequent testing if on meds that lower CD4 count
50
Q

What screening assessment is needed prior to Pt starting ABC (abacavir)?

A

**HLA-B*5701 (MUST screen for all newly diagnosed HIV PTs) either they are + or -.

**Positive Pts should NOT recieve ABC (abacavir)

-Positive status should be recorded as ABC allergy–> this drug can cause a severe hypersensitivity rxn (HSR) that can result in death

51
Q

High potential for adverse effects w/ ART meds: (list ex’s)

A 
Rash
Diarrhea
Pancreatitis
Hyperlipidemia and lipodystrophy
Increased cardiac risk
CNS effect-psychological disturbances
52
Q

Adverse Effects: PIs (protease inhibitors) list Ex’s

A 
Hyperlipidemia 
Lipodystrophy 
Hepatotoxicity
GI intolerance
Possibility of increased bleeding riskfor hemophiliacs
Drug-drug interactions
53
Q

Adverse Effects of NRTIs (lsit ex’s)

A

Lactic acidosis and hepatic steatosis (highest incidence with d4T, then ddI and ZDV, lower with TDF, ABC, 3TC, and FTC)

-Lipodystrophy(higher incidence with d4T)

54
Q

Adverse Effects of NNRTIs

A

Rash, including Stevens-Johnson syndrome

Hepatotoxicity (especially NVP)

Drug-drug interactions

55
Q

IRIS=

A

immune reconstitution syndrome= occurs after initiation of HAART

  • Inflammatory reaction in response to rapid reconstitution of CD4 counts
  • –Can “unmask” underlying opportunistic infection

*Diagnosis of exclusion

56
Q

HIV management: (list all tests)

A
  • Cd4 and viral load Q 6-12 months
  • PPD/Quantiferon gold testing
  • RPR
  • Toxoplasmosis antibody
  • Anal PAP smears,Cervical PAP smears (6-12 months)
  • If CD4 ct < 200-PCP prophylaxis,<50 MAI prophylaxis
57
Q

Pathogen: PCP

-Indication: CD4

A

<200

-Bactrim

58
Q

Pathogen: Toxo

–Indication: CD4

A
  • CD4 <100 and IgG +

- Trimethoprim-sulfa or Dapsone + Pyrimethamine

59
Q

Pathogen: MAC

-Indication: CD4

A

CD4 <50

-Clarithro/Azith

60
Q

Pathogen: TB

  • Indication: ____
  • Regimen= ?
A

+PPD(5mm)

-INH (9 months)

61
Q

Vaccinations for all HIV PTs

A 
Pneumococcal
Hepatitis A and B
Tetanus, diphtheria, pertusis
Meningitis
Influenza
COVID-19
Shingles in >50 years of age

-HPV?-definitely in those aged 26 years and younger

62
Q

Postexposure prophylaxis

A

Antiretroviral therapy decreases risk of converting to infection
Begin within 72 hours of exposure

–If source is HIV +, prophylax with agents known to be effective against that patient’s virus

  • -Generally given for 1 month
  • Truvada/Raltagravir**

(think health care workers that were exposed via needle stick, or someone that had sex with an HIV Pt, or rape victims**)

63
Q

Pre exposure prophylaxis: List meds**

A
  • Can reduce risk of HIV infection by 92%(8-2-2017)(JAMA 2019)
  • Truvada:tenofovir/emtricitabine–Daily dosing
64
Q

Recommended PREP by MSM:

-describe this demographic

A
  • Adult man without acute or established HIV infection
  • Any male sex partners in past 6 months
  • Not in a monogamous partnership with a recently tested, HIV-negative man

AND at least one of the following:

  • -Any anal sex without condoms (receptive or insertive) in past 6 months
  • -Any STI diagnosed or reported in past 6 months

–Is in an ongoing sexual relationship with an HIV-positive male partner

65
Q

Recommended PREP by MSM:

-regimen?

A
  • Tenofovir/emtricitabine (Truvada) once daily
  • Tenofovir alafenamide/emtricitabine (Descovy) approved for PrEP Oct 2019
  • -Check HIV status every 3-6 months
66
Q

PrEP Pearls

A
  • Assess HIV status prior to initiation and every 3 months after initiation
  • PrEP does NOT reduce the risk of other STIs**
  • Check renal function**
  • Check Hep B immunity!!!!** KNOW for boards
67
Q

F/U: what tests are required at every 3-month visit?

A

HIV testing

Medication monitoring/stress adherence

Counseling/behavioral risk reduction

Assess renal function, if normal, then q 6 months

Oral/rectal std screening if appropriate
Pregnancy testing if appropriate

68
Q

Perinatal transmission:

-what med should be administered to the pregnant mother w/ HIV?

A

**AZT,Zidovudine administered during pregnancy, labor and delivery , vertical transmission decreased by 2/3.

-Can start as early as 14 weeks into the pregnancy.

69
Q

List 4 Ex’s of Miscellaneous Opportunistic infxns

A
  • Coccidioidomycosis
  • Histoplasmosis
  • Blastomycosis (HIV defining illness)
  • Toxoplasmosis
70
Q

Coccidioidomycosis:

  • Sx?
  • Dx?
  • Tx?
A

-Coccidioides immitis
aka “San Joaquin Valley fever”

sx: 40% present with influenza-like illness
high fever, night sweats common
dx: serology (IgM/IgG)

tx: no tx indicated unless specific risk factors (immunosuppression)–> tx=diflucan**

71
Q

Histoplasmosis:

  • Sx?
  • Dx?
  • Tx?
A

-Histoplasma capsulatum–>Linked to bird droppings or **bat guano exposure along Ohio River Valley

  • Many infections “asymptomatic”; usually **pulmonary symptoms if presenting
  • Disseminated disease common in AIDs/ immunocompromised states

-dx: antigen test (serum/urine or CSF) or tissue bx

-Tx: itraconazole (mild/mod dz)
and Amphotericin B (severe dz)

72
Q

Blastomycosis:

  • Sx?
  • Dx?
  • Tx?
A

**Linked to soil exposure along Ohio River Valley, especially dust exposure (ex. construction)

  • Many infections “asymptomatic”; usually start as pulmonary infections with cutaneous dissemination
  • -Disseminated disease possible in all Pts

-Dx: bx & culture

-Tx: itraconazole (mild/mod dz)
and Amphotericin B (severe dz)

73
Q

toxoplasmosis:

  • Sx?
  • Dx?
  • Tx?
A

aka toxoplasma gondii

  • Assoc w/ cat boxes**
  • Usually reactivation in setting of HIV, not primary infection
  • Sx: focal neurologic findings, fever, Characteristic lesion on MRI-punched out lesion

tx: If you have HIV/AIDS, the TOC for toxoplasmosis is also pyrimethamine and sulfadiazine, with folinic acid (leucovorin).

74
Q

Histo vs blasto: what is the differentiator?

A
  • Histo= immunosuppression (AIDS defining illness)

- Blasto= no immunosuppression

Clinical Decision Making- Summer (3 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions